Empresa Neurocrine Biosciences, Inc. Berne S.E.
Acciones
NB3
US64125C1099
Biotecnología e investigación médica
Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
111,6 CHF | -.--% |
|
-.--% | -.--% |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 1 489 | 100,0 % | 1 887 | 100,0 % | +26,76 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 489 | 100,0 % | 1 887 | 100,0 % | +26,76 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01/01/92 |
Director of Finance/CFO | 44 | 01/11/17 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/11/21 |
Eiry Roberts
CTO | Chief Tech/Sci/R&D Officer | 60 | 08/01/18 |
Bill Wilson
COO | Chief Operating Officer | - | 01/09/96 |
Chief Tech/Sci/R&D Officer | 65 | 01/01/93 | |
Gary Lyons
BRD | Director/Board Member | 73 | 01/02/93 |
Todd Tushla
IRC | Investor Relations Contact | - | - |
Ingrid Delaet
LAW | General Counsel | 58 | 01/01/21 |
David Boyer
PRN | Corporate Officer/Principal | 44 | 30/09/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01/04/99 |
George Morrow
BRD | Director/Board Member | 72 | 01/10/15 |
Kevin Gorman
FOU | Founder | 66 | 01/01/92 |
Christine Poon
BRD | Director/Board Member | 71 | 11/07/23 |
Chairman | 75 | 08/02/10 | |
Richard Pops
BRD | Director/Board Member | 62 | 01/04/98 |
Gary Lyons
BRD | Director/Board Member | 73 | 01/02/93 |
Leslie Norwalk
BRD | Director/Board Member | 58 | 01/04/98 |
Shalini Sharp
BRD | Director/Board Member | 49 | 03/02/20 |
Johanna Mercier
BRD | Director/Board Member | 54 | 15/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 100 637 227 | 98 821 809 ( 98,20 %) | 0 | 98,20 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. 15.77% | 8 575 316 | 15.77% | 72 032 654 $ |
Información de la empresa
Neurocrine Biosciences, Inc.
6027 Edgewood Bend Court
92130, San Diego
+858 617 7600
http://www.neurocrine.com![Dirección Neurocrine Biosciences, Inc.(NB3)](https://cdn.zonebourse.com/static/address/149358426.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,45 % | 122 mil M | |
+21,96 % | 116 mil M | |
+25,41 % | 27,03 mil M | |
-20,05 % | 20,36 mil M | |
-16,28 % | 15,91 mil M | |
-15,89 % | 16,43 mil M | |
-44,35 % | 15,6 mil M | |
+63,91 % | 14,94 mil M | |
+124,94 % | 11,24 mil M |
- Bolsa de valores
- Acciones
- Acción NBIX
- Acción NB3
- Empresa Neurocrine Biosciences, Inc.